Skip to main content
. 2020 Apr 28;12(5):1245. doi: 10.3390/nu12051245

Table 2.

Absorption kinetics for whole blood iMg2+ and serum total magnesium concentrations and urinary magnesium content.

Parameter Placebo MgCl2 p Value
iMg2+ (n = 14)
Baseline (mg/dL) 1.25 ± 0.08 1.26 ± 0.01 0.242
AUC (mg/dL•24h) 0.84 ± 0.82 1.51 ± 0.96 0.029
Cmax (mg/dL) 1.32 ± 0.07 1.38 ± 0.13 0.034
Tmax (h) 9.54 ± 9.85 10.36 ± 9.30 0.396
Serum magnesium (n = 17)
Baseline (mg/dL) 1.95 (1.78–3.30) 2.08 (1.76–3.19) 0.491
AUC (mg/dL•24h) 14.55 (0–91.18) 27.00 (0–172.93) 0.097
Cmax (mg/dL) 2.24 (1.98–4.31) 2.38 (1.97–4.01) 0.221
Tmax (h) 11.38 ± 9.93 10.82 ± 9.11 0.396
Urine magnesium (n = 12)
Baseline (mg) 2.90 (0.81–47.15) 2.95 (0.35–88.63) 0.267
AUC (mg•24h) 139.30 ± 92.84 201.74 ± 161.63 0.118
Cmax (mg) 24.38 (13.51–81.51) 26.12 (12.91–88.63) 0.469
Tmax (h) 24.00 (0–24.00) 24.00 (0–24.00) 0.363

Whole blood concentration of iMg2+, concentration of total magnesium in serum, and total content of magnesium in urine collected during 24 h of MgCl2 versus placebo administration are shown. Values are given as the mean ± SD or the median (range) depending on the normality of the data. AUC = the area under the curve, Cmax = maximum (or peak) concentration, and Tmax = time (in hours) at which Cmax is observed. One-sided p values are shown.